Home/ Supplements/ Alpha Lipoic Acid/ Stabilized Na-R-ALA 200

Stabilized Na-R-ALA 200

product on market Capsule AST Sports Science Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Stabilized Na-R-ALA 200
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 200.0mg (198 products) 6 studies — no high-quality reviews

Other Ingredients

Dicalcium Phosphate Hypromellose Microcrystalline Cellulose Magnesium Stearate Sodium Stearyl Fumarate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended Use: As a dietary supplement, take 1 capsule three times daily with meals. For enhanced creatine effectiveness, take 2 capsules with a serving of Micronized Creatine and VP2 Whey Isolate 30 minutes after workout or athletic event.

Formulation Notes

Na-R[+]-Alpha lipoic acid

Hyper-glucose transport system

New Stabilized Na-R[+]-ALA-200 is a potent multi-soluble antioxidant that protects against oxidative stress, supports healthy cell mitochondria, and preserves youthful cellular energy. It works to shuttle more glucose into muscle tissue, modulates EPO release, and elevates intracellular glutathione for enhanced antioxidant cellular protection. Na-R[+]-ALA-200 also works to regenerate the antioxidant activity of vitamin C, vitamin E, and coenzyme Q10. Na-R[+]-ALA-200 is a state-of-the-art R[+]-ALA bonded in a sodium structure that stabilizes the fragile R[+]-ALA isomer from heat, air, light and time deterioration as well as inactive polymerization. This new sodium based R[+]-ALA form is also over 20 times more bioavailable than regular R[+]-ALA resulting in far greater peak blood levels of active, non-polymerized lipoic acid.

Made In USA

FDA Registration: 11148835776

Additional Information

Now in veggie caps!

Metadata

Product Details

UPC / SKU7 05077 00319 9
DSLD Entry Date2021-06-23
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID250580
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.